Global Cholesterol Monitors Market Significant Growth, Emerging Trends, Growth Drivers and Development Status 2022-2032

Posted by Ganesh Shinde on November 7th, 2022

In 2022, it is anticipated that the Cholesterol Monitors Market is valued US$ 2,514.6 million. The cholesterol monitors market is expected to expand at a 7.4% CAGR from 2022 to 2032 and is likely generate US$ 4,502.4 million.

Rising obesity rates and an ageing population in developed countries such as the United States, Germany, and France have increased the number of patients with high levels of bad cholesterol, necessitating a daily increase in the global demand for cholesterol monitoring kits.

Because of the growing popularity of non-invasive cholesterol monitoring technologies, the global market for cholesterol monitors is expected to grow.

Statistical Estimation in the Global Cholesterol Monitors Market

• The ageing population is a significant factor driving the increase in demand for cholesterol monitor kits. According to the Department of Economic and Social Affairs' population division, by 2050, there will be 21.1% more people in the world who are 60 or older than there were in 1990 (9.2% to 11.7%).
• According to United Health Foundation data from 2017, 12.5% of adults 60 and older had high total cholesterol. This high prevalence is expected to fuel the growth of the cholesterol monitors market in the near future.
• Due to the lack of symptoms associated with high cholesterol, comprehensive cholesterol testing is required. Triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and total cholesterol levels in the blood are all measured in these tests. Blood cholesterol levels can help reduce the risk of peripheral artery disease, heart attack, and stroke.
• If a person has a stroke, PAD, coronary heart disease, a family history of early CVD, is overweight, diabetic, has a cholesterol-related condition, or has high blood pressure, cholesterol levels should be checked. According to the Centers for Disease Control and Prevention, one in every six adults (16.3%) has high cholesterol (defined as 240 mg/dL or higher).

What are the Factors Propelling the Global Cholesterol Monitors Market?

The rising prevalence of cardiovascular diseases, combined with a growing emphasis on early diagnosis and miniaturisation of cholesterol monitors, is expected to propel the global cholesterol monitor market forward. Another factor driving the growth of the global market for cholesterol monitors is the preference for self-monitoring to improve quality of life and lead a healthy lifestyle.

Furthermore, the market is expected to grow as a result of increased focus on reducing the global burden of cardiovascular diseases (CVDs), as well as initiatives for preventive healthcare practises such as screening and health check-up programmes.

Governmental changes that provide cutting-edge healthcare facilities and awareness campaigns that are likely to raise the standard of testing also contribute to the growth of the global cholesterol monitor market.

How Start-ups are Adding Value to the Global Cholesterol Monitors Market?

The swelling dispersion of start-ups in the cholesterol monitors market has improved the product quality and increased global sales. Besides, to gain a competitive edge, new start-ups are working on novel developments and launching new products, such as

• In March 2021, Ro scored a hefty US$ 500 Million Series D round led by existing investors General Catalyst, FirstMark Capital, and TQ Ventures. The company has raised 6 million since its founding in 2017.

Kit diagnostic tests for patients directly through Ro’s platform, providing the objective health data necessary to inform high-quality care for a range of health conditions, such as:

• Sexual health
• Cholesterol
• Hypertension
• Diabetes.

• NuGenomics-a start-up launched in July 2021, uses patented technology to prognosis, prevent, diagnose, and cure lifestyle disorders by providing health-oriented data, insights, and actionable suggestions made by its AI/ML system as opposed to a nutritionist.

The startup's product offerings include the Rs 8,999 Genetic Test Report, which helps people understand their predispositions to cholesterol, HDL, LDL, Triglyceride, and Blood Sugar levels, among other conditions, to help their existing trainers and nutritionists.

Key Players

• Roche Diagnostics
• PTS Diagnostics
• Omron Healthcare, Inc.
• ACON Laboratories, Inc.
• AccuTech
• LLC
• Alere Inc.
• Siemens
• Medline Industries, Inc.
• Abaxis, Inc.
• ManthaMed
• Fisher Scientific

Segments Covered

• Product Type
• End User

Key Companies Profiled

• Roche Diagnostics
• PTS Diagnostics
• Omron Healthcare, Inc
• ACON Laboratories, Inc.,
• AccuTech, LLC
• Alere Inc.
• Siemens
• Medline Industries, Inc.
• Abaxis, Inc.
• ManthaMed
• Fisher Scientific

Key Segments Covered in the Cholesterol Monitors Industry Survey

By Product Type:

• Single-sided COD Chip-On-Flex
• Other Chip-On-Flex Types

By End Users:

• Military
• Medical
• Aerospace
• Electronics
• Other Verticals

Read More@https://www.futuremarketinsights.com/reports/cholesterol-monitors-market